Trial intelligence / Profile preview

Plant Stanol Ester and COVID-19 Vaccine Response

NCT04844346Terminated

Sponsor
Maastricht University Medical Center+
Start
Apr 2021
Primary completion
Jan 2022
Countries
1
01

Overview

Randomised, double-blind trial in obesity, sponsored by Maastricht University Medical Center+. Primary endpoint: Vaccine specific antibody titers at 4 weeks. Started Apr 2021; status: terminated.

02

Conditions

obesity

Beyond the preview

Go deeper on NCT04844346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04844346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call